0
Signin
countryflagUS

18889881171

MSFT 425.025 -0.9035% AAPL 220.43 0.8648% NVDA 115.85 1.4004% GOOGL 172.44 -0.1101% GOOG 174.27 -0.0573% AMZN 182.99 1.1945% META 460.09 -0.2558% AVGO 152.64 0.859% TSLA 224.8499 4.102% TSM 161.61 1.1327% LLY 823.56 -4.2238% V 257.56 1.3338% JPM 209.535 0.453% UNH 562.83 0.5502% NVO 129.31 -1.7401% WMT 70.206 -0.5581% LVMUY 143.15 0.9022% XOM 116.85 1.5999% LVMHF 714.04 0.4982% MA 436.96 1.0429%

Reliq Health Technologies Inc

Healthcare US RQHTF

0.05USD
-0.04(44.44%)

Last update at 2024-07-24T19:54:00Z

Day Range

0.050.07
LowHigh

52 Week Range

0.190.50
LowHigh

Fundamentals

  • Previous Close 0.09
  • Market Cap44.66M
  • Volume45000
  • P/E Ratio-
  • Dividend Yield4.02%
  • EBITDA-1.20961M
  • Revenue TTM14.62M
  • Revenue Per Share TTM0.08
  • Gross Profit TTM 5.30M
  • Diluted EPS TTM-0.02

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Type yearly yearly yearly yearly yearly
Date 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Income before tax -8.17098M -11.78055M -11.12236M -13.00407M -13.79655M
Minority interest - - - - 0.00000M
Net income -8.08754M -11.82717M -11.15855M -12.11078M -13.79655M
Selling general administrative 10.03M 10.11M 8.82M 7.43M 12.00M
Selling and marketing expenses 0.49M 0.52M 0.35M 0.27M 0.38M
Gross profit 5.30M 0.86M 0.17M 0.00783M 1.15M
Reconciled depreciation 0.12M 0.13M 0.45M 0.63M 0.00000M
Ebit -8.29575M -11.62710M -11.16596M -13.89736M -13.63327M
Ebitda -8.10385M -11.50135M -10.72055M -13.26320M -11.54175M
Depreciation and amortization 0.19M 0.13M 0.45M 0.63M -
Non operating income net other - - - - 0.00000M
Operating income -8.29575M -11.62710M -11.16596M -13.89736M -11.54175M
Other operating expenses 16.85M 13.09M 12.31M 13.63M 14.92M
Interest expense 0.04M 0.05M 0.04M 0.00000M 0.00003M
Tax provision - - - - -
Interest income 0.08M - - 0.00000M 0.00003M
Net interest income 0.04M -0.04662M -0.03619M 0.00000M 0.00003M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense -0.08344M 0.05M 0.04M -0.89329M 0.00000M
Total revenue 8.55M 1.46M 1.14M 0.18M 2.27M
Total operating expenses 13.60M 12.49M 11.34M 13.46M 13.80M
Cost of revenue 3.25M 0.60M 0.97M 0.17M 1.12M
Total other income expense net 0.12M -0.15345M 0.04M 0.89M -1.14390M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -8.17098M -11.78055M -11.12236M -13.00407M -13.79655M
Net income applicable to common shares -8.17098M -11.78055M -11.12236M -13.00407M -13.79655M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Type yearly yearly yearly yearly yearly
Date 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Total assets 10.27M 3.46M 2.70M 3.76M 12.36M
Intangible assets - - - - 0.00000M
Earning assets - - - - -
Other current assets 0.10M 0.14M 0.10M 0.08M 0.00000M
Total liab 3.90M 2.46M 1.70M 1.10M 0.53M
Total stockholder equity 6.37M 1.00M 1.00M 2.66M 11.83M
Deferred long term liab - - - - 0.00000M
Other current liab 3.59M 2.06M - 0.20M 0.14M
Common stock 62.57M 49.84M 40.25M 31.54M 28.72M
Capital stock 62.57M 49.84M 40.25M 31.54M -
Retained earnings -69.86560M -61.69461M -49.91406M -38.94236M -25.93829M
Other liab - - - - 0.00000M
Good will - - - - 0.00000M
Other assets 3.12M - - - 0.00000M
Cash 0.13M 0.23M 0.01M 0.35M 9.80M
Cash and equivalents - - - - -
Total current liabilities 3.71M 2.24M 1.42M 1.10M 0.53M
Current deferred revenue - - - - -
Net debt 0.17M 0.18M 0.45M -0.34503M -9.80092M
Short term debt 0.12M 0.18M 0.18M - 0.00000M
Short long term debt - - - - 0.00000M
Short long term debt total 0.31M 0.40M 0.46M - -
Other stockholder equity 0.14M 12.86M 10.67M 10.07M 9.05M
Property plant equipment 0.18M 0.28M 0.35M 2.54M 0.00000M
Total current assets 6.97M 3.18M 2.36M 1.23M 12.36M
Long term investments - - - - 0.00000M
Net tangible assets 6.37M 1.00M 1.00M 2.81M 11.83M
Short term investments 0.10M 0.10M 0.12M 0.12M 0.12M
Net receivables 6.36M 2.16M 1.03M 0.61M 0.03M
Long term debt 0.04M 0.04M 0.04M - 0.00000M
Inventory 0.27M 0.55M 1.09M 0.07M 0.00000M
Accounts payable 3.59M 2.06M 1.24M 0.90M 0.39M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income 13.52M 12.86M 10.67M 10.07M 9.05M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 3.12M - - 2.54M 0.00000M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 3.30M 0.28M 0.35M 2.54M 0.00000M
Capital lease obligations 0.27M 0.36M 0.42M - 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Type yearly yearly yearly yearly yearly
Date 2022-06-30 2021-06-30 2020-06-30 2019-06-30 2018-06-30
Investments 0.00000M 0.02M 0.02M 0.02M -0.10650M
Change to liabilities 1.53M 0.82M 0.29M 0.57M -0.06942M
Total cashflows from investing activities - 0.02M 0.37M 0.37M -0.10650M
Net borrowings -0.09773M -0.12057M -0.00780M -0.00780M -0.00780M
Total cash from financing activities 7.93M 7.30M 5.55M 2.51M 17.57M
Change to operating activities 0.04M -0.04725M -0.01767M 2.32M -2.24123M
Net income -8.17098M -11.78055M -11.12236M -13.00407M -13.79655M
Change in cash -0.09352M 0.21M -0.33223M -9.45589M 9.31M
Begin period cash flow 0.23M 0.01M 0.35M 9.80M 0.49M
End period cash flow 0.13M 0.23M 0.01M 0.35M 9.80M
Total cash from operating activities -8.02800M -7.10602M -6.25720M -11.96361M -8.15110M
Issuance of capital stock 0.00000M 3.04M - 0.00000M -
Depreciation 0.12M 0.13M 0.45M 0.63M 0.63M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid - - - - 0.00000M
Change to inventory 0.27M 0.55M 0.97M -3.24177M -3.24177M
Change to account receivables -0.10436M -1.13155M -0.47945M -0.20883M -1.13717M
Sale purchase of stock - - - - 0.00000M
Other cashflows from financing activities 8.03M 4.38M 5.60M -0.05706M 2.57M
Change to netincome 5.50M 4.36M 3.66M 0.96M 9.09M
Capital expenditures 0.00000M 0.00000M 0.05M 0.05M 0.05M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital -5.47215M 0.18M 0.76M -0.45240M -3.44782M
Stock based compensation 5.51M 4.36M 3.75M 1.33M 7.93M
Other non cash items -0.00758M 0.05M 0.04M -0.50418M 1.16M
Free cash flow -8.02800M -7.10602M -6.30741M -11.96361M -8.15110M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RQHTF
Reliq Health Technologies Inc		 -0.04 44.44% 0.05 - - 2.85 6.99 3.90 -10.3287
GEHC
GE HealthCare Technologies Inc.		 1.08 1.36% 80.77 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 5.39 2.93% 189.64 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 9.07 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 0.10 2.10% 4.86 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada.

Reliq Health Technologies Inc

175 Longwood Rd S, Hamilton, ON, Canada, L8P 0A1

Key Executives

Name Title Year Born
Dr. Lisa Crossley P.Eng, Ph.D. CEO & Director NA
Mr. Michael Frankel CFA Chief Financial Officer NA
Mr. Dave McKay Chief Technology & Innovation Officer NA
Mr. Lucas Smithen Chief Product Officer NA
Dr. Joyce Johnson M.D. Chief Medical Officer & Medical Advisory Board Member NA
Mr. Chris Ryan Chief Strategy Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.